Abstract
Monitoring therapeutic response is fundamental and crucial to clinical oncology because most chemotherapy drugs are effective in only subgroups of patients. Unfortunately, our current understanding of tumor biology does not allow us to predict accurately which ...
Cite
CITATION STYLE
APA
Kim, E. E. (2010). Personalizing Cancer Therapy with FDG PET: From RECIST to PERCIST. Journal of Nuclear Medicine, 51(5), 821–822. https://doi.org/10.2967/jnumed.109.072934
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free